XM does not provide services to residents of the United States of America.
T
T

Textron

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Families of Marines killed in 2022 Osprey crash sue Bell Textron, Boeing, Rolls Royce -Axios

MEDIA-Families of Marines killed in 2022 Osprey crash sue Bell Textron, Boeing, Rolls Royce -Axios WASHINGTON, May 24 (Reuters) - -- Source link: https://tinyurl.com/rpc2zdfr -- Note: Reuters has not verified this story and does not vouch for its accuracy (Washington newsroom)
B
R
T

Textron Systems Collaborates With Kodiak To Develop Uncrewed Military Vehicle

BRIEF-Textron Systems Collaborates With Kodiak To Develop Uncrewed Military Vehicle May 20 (Reuters) - Textron Inc TXT.N : TEXTRON SYSTEMS COLLABORATES WITH KODIAK TO DEVELOP UNCREWED MILITARY VEHICLE Source text for Eikon: ID:nPn1snHLFa Further company coverage: TXT.N
T

What we know about the crashed helicopter carrying Iran's president

FACTBOX-What we know about the crashed helicopter carrying Iran's president Changes media identifier By Gerry Doyle May 20 (Reuters) - The helicopter that crashed in Iran on Sunday, killing the country's president and foreign minister in mountain fog, was a Bell 212 model, Iranian state media reported. A civilian version of the ubiquitous Vietnam War-era UH-1N "Twin Huey," such helicopters are in wide use globally by both governments and private operators: WHAT ARE THE HELICOPTER'S ORIGINS?
L
T

What we know about the crashed helicopter carrying Iran's president

FACTBOX-What we know about the crashed helicopter carrying Iran's president By Gerry Doyle May 20 (Reuters) - A Bell 212 helicopter carrying Iran's president and foreign minister crashed on Sunday , according to Iranian state media, as it flew through mountains in heavy fog. All are feared dead, an Iranian official said on Monday as search teams located the wreckage.
T

U.S. Bath & Body Works, Under Armour, Viking Therapeutics

U.S. RESEARCH ROUNDUP-Bath & Body Works, Under Armour, Viking Therapeutics May 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Bath & Body Works, Under Armour and Viking Therapeutics, on Friday. HIGHLIGHTS * Advanced Drainage Systems Inc WMS.N : Barclays raises target price to $202 from $189 * Bath & Body Works Inc BBWI.N : JP Morgan raises to neutral from underweight * Tanger Inc SKT.N : Scotiabank raises to sect
B
C
G
M
T
A
A
C
D
T

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.